Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 2/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.30 |
| ▸ | GBA1 | P04062 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17129705 | 0.84 | RARB (0.37) | HRH3GBA1 | |
| SCHEMBL16624152 | 0.82 | HRH3 (0.33) | HRH3ALDH1A1SMN1; SMN2CTDSP1ACHE | |
| SCHEMBL14227671 | 0.78 | ALDH1A1 (0.38) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL16624157 | 0.78 | HRH3 (0.32) | HRH3ALDH1A1SMN1; SMN2CTDSP1CHRM2 | |
| SCHEMBL17676149 | 0.75 | RARB (0.33) | — | |
| SCHEMBL16624153 | 0.75 | HRH3 (0.32) | HRH3ALDH1A1SMN1; SMN2CTDSP1CHRM2 | |
| SCHEMBL17675719 | 0.75 | RXRA (0.43) | — | |
| SCHEMBL17675717 | 0.74 | CYP3A4 (0.37) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL16624155 | 0.74 | ESR1 (0.40) | HRH3ALDH1A1SMN1; SMN2CHRM2CHRM3 | |
| SCHEMBL14227659 | 0.74 | RARB (0.35) | ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9730875-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2017-08-15 | — | — | US | disclosed |
| US-20160143829-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA | 2016-05-26 | — | — | US | disclosed |
| US-9284261-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2016-03-15 | — | — | US | disclosed |
| US-20150099810-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099810-A1 | PHOTOLABILE PRO-FRAGRANCES | TRPA1, PSAP, CRY1 | HRH3 588/4885ALDH1A1 234/4885SMN1; SMN2 2945/4885 |
| US-20160143829-A1 | PHOTOLABILE PRO-FRAGRANCES | TRPA1, PSAP, CRY1 | HRH3 588/4885ALDH1A1 234/4885SMN1; SMN2 2945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.